CD5 and T-cell leukemia: For example, CD5 CAR-NK cells or CD7 CAR-NK cells constructed by human NK-92 cell line showed consistent, specific, and potent anti-tumor activity against a variety of T-cell leukemia and lymphoma in vitro (93, 96).